NAMS
NewAmsterdam Pharma Company NV

466
Mkt Cap
$4.04B
Volume
1.12M
52W High
$42.00
52W Low
$14.06
PE Ratio
-17.44
NAMS Fundamentals
Price
$36.17
Prev Close
$35.61
Open
$35.33
50D MA
$36.70
Beta
0.80
Avg. Volume
1.03M
EPS (Annual)
-$2.56
P/B
5.54
Rev/Employee
$670,044.12
Loading...
Loading...
News
all
press releases
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten research firms that are presently covering the stock...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Stempoint Capital LP Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS
Stempoint Capital LP lifted its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 46.0% in the second quarter, according to the company in its most recent 13F filing with...
MarketBeat·2d ago
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down - Here's Why
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down - Here's Why...
MarketBeat·7d ago
News Placeholder
JPMorgan Chase & Co. Increases Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
JPMorgan Chase & Co. increased its stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 47.2% during the 2nd quarter, according to its most recent disclosure with the Securities...
MarketBeat·8d ago
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month High - Here's Why
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month High - What's Next...
MarketBeat·14d ago
News Placeholder
Bank of New York Mellon Corp Acquires New Position in NewAmsterdam Pharma Company N.V. $NAMS
Bank of New York Mellon Corp bought a new position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) during the second quarter, according to the company in its most recent...
MarketBeat·20d ago
News Placeholder
Letko Brosseau & Associates Inc. Invests $213,000 in NewAmsterdam Pharma Company N.V. $NAMS
Letko Brosseau & Associates Inc. bought a new stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) during the 2nd quarter, according to its most recent filing with the SEC...
MarketBeat·25d ago
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Up 7% - Time to Buy?
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 7% - Here's Why...
MarketBeat·26d ago
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down - Here's What Happened
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Research Analysts Offer Predictions for NAMS FY2026 Earnings
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - Stock analysts at Cantor Fitzgerald lowered their FY2026 EPS estimates for shares of NewAmsterdam Pharma in a report issued on Thursday...
MarketBeat·1mo ago

Latest NAMS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.